Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.1519 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.12882 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.14241 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.07841 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.0899 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.1985 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.16241 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.11457 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.11353 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.12983 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.12128 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.10236 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.12482 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.23642 | 10 |